This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Current Discounted Rates End In:

  • 00
  • 00
  • 00
  • 00
Delivered as Hybrid Event from September 20-30, 2021
Live In-Person Experience Delivered September 20-23Boston Convention and Exhibition Center

Louis Diorazio, Ph.D.
Principal Scientist, Chemical Development at AstraZeneca


Louis Diorazio is Principal Scientist in Chemical Development in AstraZeneca based at Macclesfield in the UK. He obtained a BSc and PhD from Imperial College, London in the area of organofluorine chemistry with Dave Widdowson. This was followed by a postdoc position with Phil Magnus at the University of Texas at Austin on the total synthesis of taxol. Louis joined Ciba Corporate Research working on agrochemicals then moved to medicinal chemistry following the Novartis merger. In 1998, he moved to Zeneca in Process Development and has remained through various department and corporate restructuring. He has worked on conventional small molecules and oligonucleotides and has departmental accountability for Route Design, sustainability and oligonucleotide drug substance. In addition, Louis is currently co-chair of the ACS Green chemistry Institute Pharmaceutical Round Table

Agenda Sessions

  • Oligonucleotide Starting Materials – Drivers (or Disasters) for Sustainability